Southeast Asia Report

Southeast Asia Bioprocessing Market

$5,998$9,998

Deep-dive into Southeast Asia’s biopharma landscape with a comprehensive market & company analysis. Access in-depth market and company analysis of 25 biopharmaceutical companies in Southeast Asia working on various biologics products such as vaccines, monoclonal antibodies, ADCs, biosimilars and cell therapies.

KEY TAKEAWAYS
  • Insights into the buying decisions of your potential clients, the key stakeholders and the effect of COVID-19 on their budget and therapeutic pipeline
  • Find your potential partners interested in your latest technologies or services offered
  • Evaluate your business model by doing a competitive study across various organisations listed
Clear
 
product details
  • 1Table of Contents
  • 2Companies Mentioned
  • 3User Access

SECTION 1

  • Preface
  • Report scope & data coverage
  • IMAPAC’s research methodology

SECTION 2: MARKET OVERVIEW

  • Southeast Asia region
  • Country-wise – Thailand, Singapore, Malaysia, Indonesia, Vietnam
  • Driving factors and limitations for each market
  • Scope of growth for each market

SECTION 3: COMPANY OVERVIEW

  • Active pipelines
  • Partnerships and collaborations
  • Technology, equipment and solution providers
  • Future expansion plans

SECTION 4: COMPANY ANALYSIS

  • Customer profile, market trends and procurement process
  • Competition and market tactics
  • Companies’ KPI
  • Focus applications
  • Changes in regulations, per market
  • Deciding factors in choosing a vendor
  • Factors influencing their buying decisions
  • Effect of COVID-19 has on their budget for the next 3 years
  • Stakeholders and decision makers for procurement
  • Best supplier and the equipment used by their team
  • Therapeutic areas having new pipeline in their organization in the next 3 years?
  • Interview
  • References

SECTION 5

  • Bibliography
  • Disclaimer
  • About us
  • Our other reports

THAILAND

  • Siam Biosciences
  • Government Pharmaceutical Organisation
  • Tcels
  • Kingen Biotech
  • Bio-Net Asia
  • Queen Saovabha Memorial Institute

SINGAPORE

  • SingCell
  • BTI
  • Cell Research Corporation
  • Tessa Therapeutics
  • Dot Bio
  • Travecta Therapeutics
  • Prestige Biopharma
  • Esco Aster
  • Lion TCR

MALAYSIA

  • Malaysian Vaccine Pharmaceuticals
  • National Institutes of Biotechnology Malaysia

INDONESIA

  • Biofarma
  • PT Kalbe Global Biomedika
  • Daewoong Infion
  • Bandung Institute of Technology

VIETNAM

  • Nanogen Pharmaceutical Biotechnology
  • Vietnam Academy of Science and Technology
  • Vabiotech

Single - User Access

This license grants the right of use of the purchased report to a single recipient only. You may access the material on your computer, as and when required, for your own personal use.

Multi - User Access

Upto 3 users: This license grants the right of use of the purchased report by upto 3 users of the same firm/enterprise.

Corporate Access

Unlimited user access (Within your organization): This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the number of users.

Related products
CMO Biologics Report
$5,998$9,998

Asia-Pacific Biologic CMO Facilities

  • Region: APAC
  • Companies Featured: 42
  • Parameters: Facility Design, GMP Certification, Partnerships & Collaborations, Capacity Planning & Future Expansion
  • Topics: Biologics Contract Manufacturing Asia-Pacific
Bioprocessing Facilities Report
$5,998$9,998

Asia Pacific Bioprocessing Facilities

  • Region: APAC
  • Companies Featured: 65
  • Parameters: Facility Design, GMP Certification, Partnerships & Collaborations, Capacity Planning & Future Expansion
  • Topics: Bioprocessing Facilities Asia-Pacific
chat
Get In Touch

    padlock

    By clicking the "Submit" button, you are agreeing to IMAPAC's Privacy Policy.

    bag